+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

How can we provide the best care for our patients with immune thrombocytopenic pupura?

How can we provide the best care for our patients with immune thrombocytopenic pupura?

Mayo Clinic Proceedings 79(4): 456-457

Please choose payment method:

(PDF emailed within 1 workday: $29.90)

Accession: 049244953

Download citation: RISBibTeXText

PMID: 15065609

Related references

How Can We Provide the Best Care for Our Patients With Immune Thrombocytopenic Purpura?. Mayo Clinic Proceedings 79(4): 456-457, 2004

Immune thrombocytopenic pupura-induced reversible posterior leukoencephalopathy successfully treated by rituximab. Annals of Hematology 90(6): 731-732, 2011

Thrombocytopenic pupura and pregnancy. Revista Chilena de Obstetricia Y Ginecologia 40(3): 162-168, 1975

Not all cases of idiopathic thrombocytopenic purpura [correction of pupura] are what they might first seem. Clinical and Laboratory Haematology 24(4): 261-262, 2002

Thrombotic thrombocytopenic pupura (TTP) dinner symposium proceedings. Expert Review of Hematology 9(8): 733-735, 2016

High incidence of myocardial damage in thrombotic thrombocytopenic pupura. Kidney & Blood Pressure Research 23(3-5): 281, 2000

Thrombotic thrombocytopenic pupura (TTP)--remission following treatment with high-dose immunoglobulin. Japanese Journal of Clinical Hematology 32(12): 1564-1568, 1991

Traumatic splenic injury managed with arterial embolisation in a patient with idiopathic thrombocytopenic pupura. Cardiovascular and Interventional Radiology 33(4): 877-879, 2010

Inhibition of platelet GPIIb/IIIa binding to fibrinogen by serum factors: studies of circulating immune complexes and platelet antibodies in patients with hemophilia, immune thrombocytopenic purpura, human immunodeficiency virus-related immune thrombocytopenic purpura, and systemic lupus erythematosus. Journal of Laboratory & Clinical Medicine 117(3): 209-217, 1991

Long-term dosing of AMG 531 in thrombocytopenic patients with immune thrombocytopenic purpura: 2-year update. 2007

Lack of compensatory megakaryocytopoiesis in HIV-1-seropositive thrombocytopenic individuals compared with immune thrombocytopenic purpura patients. Aids 5(11): 1345-1350, 1991

Comparison of platelet function and bleeding in thrombocytopenic patients with immune thrombocytopenic purpura (ITP) and chemotherapy-induced thrombocytopenia (CIT). 2007

An open-label extension study evaluating the safety and efficacy of romiplostim for up to 3.5 years in thrombocytopenic Japanese patients with immune thrombocytopenic purpura (ITP). International Journal of Hematology 95(6): 652-659, 2012

An open-label, dose-finding study evaluating the safety and platelet response of a novel thrombopoietic protein in thrombocytopenic adult patients with immune thrombocytopenic purpura. Blood 102(11): 86a, 2003

Plasma thrombopoietin concentrations in thrombocytopenic and non-thrombocytopenic patients in a neonatal intensive care unit. British Journal of Haematology 104(1): 90-92, 1999